Frontiers in public health · 2025
Meta-analysis of factors influencing depression in cervical cancer patients.
СтатьяМетаанализСистематический обзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wang Rong, Liu Bang, Wei Si-Wen, Liu Yi-Ran, Zhong Yi, Han Li, Luo Huai-Qing
Аннотация
BACKGROUND: Depression in cervical cancer (CC) patients concurrently compromises disease management and quality of life. However, significant discrepancies persist among existing studies regarding the determinants of depression in this population worldwide. To address this gap, this study employs meta-analysis to systematically identify and synthesize the contributing factors to depression among cervical cancer patients.
AIM: To provide evidence-based references for mitigating depression risk among cervical cancer patients.
METHODS: Literature was searched in databases including CNKI, Wanfang, VIP, CBM, Web of Science, PubMed, and EMBASE from their inception until March 2025. The literature was screened, selected, quality assessed, and data extracted and analyzed. Meta-analysis was conducted using Revman 5.4 and Stata 18 software, with odds ratios (OR) and their 95% confidence intervals (CI) as the observed indicators.
RESULTS: A total of 1,108 articles were retrieved, with 15 articles ultimately included in the analysis. The results indicate that low educational attainment (OR = 3.25, 95% CI: 2.02-5.22), age ≥45 years (OR = 1.67, 95% CI: 1.09-2.55), inter-household monthly income disparity (OR = 3.06, 95% CI: 1.87-5.00), advanced tumor stage (OR = 1.99, 95% CI: 1.28-3.11), low social support (OR = 2.48, 95% CI: 1.95-3.16), moderate to severe pain (OR = 2.86, 95% CI: 1.76-4.65), limited disease awareness (OR = 2.58, 95% CI: 1.88-3.55), and undergoing hysterectomy (OR = 4.69, 95% CI: 3.03-7.24) are significant risk factors for depression in cervical cancer patients.
CONCLUSION: The occurrence of depression in cervical cancer patients is influenced by multiple factors. Healthcare professionals and family members should conduct comprehensive assessments of patients' conditions to implement targeted prevention and intervention measures, thereby enhancing the psychological wellbeing of patients.
SYSTEMATIC REVIEW REGISTRATION: https://inplasy.com/, identifier: INPLASY202560039.
AIM: To provide evidence-based references for mitigating depression risk among cervical cancer patients.
METHODS: Literature was searched in databases including CNKI, Wanfang, VIP, CBM, Web of Science, PubMed, and EMBASE from their inception until March 2025. The literature was screened, selected, quality assessed, and data extracted and analyzed. Meta-analysis was conducted using Revman 5.4 and Stata 18 software, with odds ratios (OR) and their 95% confidence intervals (CI) as the observed indicators.
RESULTS: A total of 1,108 articles were retrieved, with 15 articles ultimately included in the analysis. The results indicate that low educational attainment (OR = 3.25, 95% CI: 2.02-5.22), age ≥45 years (OR = 1.67, 95% CI: 1.09-2.55), inter-household monthly income disparity (OR = 3.06, 95% CI: 1.87-5.00), advanced tumor stage (OR = 1.99, 95% CI: 1.28-3.11), low social support (OR = 2.48, 95% CI: 1.95-3.16), moderate to severe pain (OR = 2.86, 95% CI: 1.76-4.65), limited disease awareness (OR = 2.58, 95% CI: 1.88-3.55), and undergoing hysterectomy (OR = 4.69, 95% CI: 3.03-7.24) are significant risk factors for depression in cervical cancer patients.
CONCLUSION: The occurrence of depression in cervical cancer patients is influenced by multiple factors. Healthcare professionals and family members should conduct comprehensive assessments of patients' conditions to implement targeted prevention and intervention measures, thereby enhancing the psychological wellbeing of patients.
SYSTEMATIC REVIEW REGISTRATION: https://inplasy.com/, identifier: INPLASY202560039.